PRWT Services, Inc., through its wholly-owned subsidiary, Cherokee Pharmaceuticals LLC, has acquired Merck’s Cherokee chemical manufacturing plant in Riverside, PA. Cherokee has also entered into a five-year supply agreement with Merck, valued at $100-200 million annually. The sale of the site is part of Merck’s global restructuring of its manufacturing operations. PRWT chairman and chief executive officer Willie F. Johnson remarked, “The acquisition of the Cherokee plant ...